Milton Erman

Summary

Affiliation: The Scripps Research Institute
Country: USA

Publications

  1. ncbi An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia
    Milton Erman
    Pacific Sleep Medicine Services, San Diego, CA 92121, USA
    Sleep Med 7:17-24. 2006
  2. ncbi Therapeutic options in the treatment of insomnia
    Milton K Erman
    Department of Psychiatry, University of California at San Diego School of Medicine, San Diego, CA 92121, USA
    J Clin Psychiatry 66:18-23; quiz 42-3. 2005
  3. ncbi Selected sleep disorders: restless legs syndrome and periodic limb movement disorder, sleep apnea syndrome, and narcolepsy
    Milton K Erman
    Department of Psychiatry, School of Medicine, University of California, San Diego, CA, USA
    Psychiatr Clin North Am 29:947-67; abstract viii-ix. 2006
  4. ncbi Zolpidem extended-release 12.5 mg associated with improvements in work performance in a 6-month randomized, placebo-controlled trial
    Milton Erman
    Avastra USA, Pacific Sleep Medicine Services, San Diego, CA 92121, USA
    Sleep 31:1371-8. 2008
  5. ncbi Do sleep disorders and associated treatments impact glucose metabolism?
    Naresh M Punjabi
    Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, Maryland 21224, USA
    Drugs 69:13-27. 2009
  6. ncbi A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia
    Milton K Erman
    Pacific Sleep Medicine Services, Inc, San Diego, CA, USA
    J Clin Sleep Med 4:229-34. 2008
  7. ncbi Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study
    Jonathan R L Schwartz
    Integris Sleep Disorders Center of Oklahoma, 4200 S Douglas, Suite 313, Oklahoma City, OK 73109, USA
    Chest 124:2192-9. 2003
  8. ncbi Effects of temazepam 7.5 mg and temazepam 15 mg on sleep maintenance and sleep architecture in a model of transient insomnia
    Milton K Erman
    Pacific Sleep Medicine Services, San Diego, California 92121, USA
    Curr Med Res Opin 21:223-30. 2005
  9. ncbi Comparison of temazepam 7.5 mg with temazepam 15 mg for the treatment of transient insomnia
    Milton K Erman
    Pacific Sleep Medicine Services, San Diego, CA 92121, USA
    Curr Med Res Opin 20:441-9. 2004
  10. ncbi Validation of the ApneaLink for the screening of sleep apnea: a novel and simple single-channel recording device
    Milton K Erman
    Pacific Sleep Medicine Services, San Diego, CA, USA
    J Clin Sleep Med 3:387-92. 2007

Collaborators

Detail Information

Publications12

  1. ncbi An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia
    Milton Erman
    Pacific Sleep Medicine Services, San Diego, CA 92121, USA
    Sleep Med 7:17-24. 2006
    ..To evaluate the efficacy, safety, and dose response of Ramelteon, a novel highly selective MT1/MT2 receptor agonist, in patients with chronic primary insomnia...
  2. ncbi Therapeutic options in the treatment of insomnia
    Milton K Erman
    Department of Psychiatry, University of California at San Diego School of Medicine, San Diego, CA 92121, USA
    J Clin Psychiatry 66:18-23; quiz 42-3. 2005
    ....
  3. ncbi Selected sleep disorders: restless legs syndrome and periodic limb movement disorder, sleep apnea syndrome, and narcolepsy
    Milton K Erman
    Department of Psychiatry, School of Medicine, University of California, San Diego, CA, USA
    Psychiatr Clin North Am 29:947-67; abstract viii-ix. 2006
    ....
  4. ncbi Zolpidem extended-release 12.5 mg associated with improvements in work performance in a 6-month randomized, placebo-controlled trial
    Milton Erman
    Avastra USA, Pacific Sleep Medicine Services, San Diego, CA 92121, USA
    Sleep 31:1371-8. 2008
    ..Although most research on pharmacotherapy for chronic insomnia focuses on changes in sleep outcomes, the functional impact of treatment is also of great importance to patients, families, physicians, and employers...
  5. ncbi Do sleep disorders and associated treatments impact glucose metabolism?
    Naresh M Punjabi
    Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, Maryland 21224, USA
    Drugs 69:13-27. 2009
    ..In conclusion, there is limited evidence on whether sleep disorders alter glucose metabolism and whether treatment can reduce the excess metabolic risk...
  6. ncbi A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia
    Milton K Erman
    Pacific Sleep Medicine Services, Inc, San Diego, CA, USA
    J Clin Sleep Med 4:229-34. 2008
    ..To evaluate the polysomnographic efficacy and the safety of a range of doses of eszopiclone relative to placebo in patients with primary insomnia. Zolpidem 10 mg was included as an active control...
  7. ncbi Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study
    Jonathan R L Schwartz
    Integris Sleep Disorders Center of Oklahoma, 4200 S Douglas, Suite 313, Oklahoma City, OK 73109, USA
    Chest 124:2192-9. 2003
    ....
  8. ncbi Effects of temazepam 7.5 mg and temazepam 15 mg on sleep maintenance and sleep architecture in a model of transient insomnia
    Milton K Erman
    Pacific Sleep Medicine Services, San Diego, California 92121, USA
    Curr Med Res Opin 21:223-30. 2005
    ..To compare the effects of temazepam 7.5 mg and temazepam 15 mg on sleep maintenance during the last third of the night (last 160 min) and on sleep architecture throughout the night...
  9. ncbi Comparison of temazepam 7.5 mg with temazepam 15 mg for the treatment of transient insomnia
    Milton K Erman
    Pacific Sleep Medicine Services, San Diego, CA 92121, USA
    Curr Med Res Opin 20:441-9. 2004
    ..To demonstrate the equivalent efficacy of temazepam 7.5 mg and temazepam 15 mg for the treatment of transient insomnia...
  10. ncbi Validation of the ApneaLink for the screening of sleep apnea: a novel and simple single-channel recording device
    Milton K Erman
    Pacific Sleep Medicine Services, San Diego, CA, USA
    J Clin Sleep Med 3:387-92. 2007
    ..The purpose of the study was to validate the ApneaLink device (ResMed Corporation, Poway, Calif) for use as a screening tool for sleep apnea in clinical practice...
  11. ncbi Evaluation of the safety of modafinil for treatment of excessive sleepiness
    Thomas Roth
    Henry Ford Sleep Disorders Center, Detroit, MI 48202, USA
    J Clin Sleep Med 3:595-602. 2007
    ..Safety and tolerability data from 6 randomized, double-blind, placebo-controlled studies were combined to evaluate modafinil across these different patient populations...
  12. ncbi Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus
    Daniel Einhorn
    Scripps Whittier Institute for Diabetes, La Jolla, California 92037, USA
    Endocr Pract 13:355-62. 2007
    ..To assess the prevalence of sleep apnea (SA) in adults with type 2 diabetes mellitus (T2DM) and examine whether demographics and comorbid factors were associated with SA in this population...